XML 72 R62.htm IDEA: XBRL DOCUMENT v3.22.2.2

Interest in joint venture - Schedule of movement in interest in joint venture (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Disclosure of joint ventures [line items]
Beginning balance	$ 41,236
Ending balance	34,687
Overland ADCT BioPharma
Disclosure of joint ventures [line items]
Beginning balance	41,236	$ 47,908
Share of results in joint venture	(6,549)	(3,906)
Ending balance	$ 34,687	$ 44,002

X

- Definition

Share Of Profit (Loss) Of Joint Ventures Accounted For Using Equity Method, Proportionate Share Of Results

+ References

No definition available.

+ Details

Name:	adc_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethodProportionateShareOfResults
Namespace Prefix:	adc_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.

+ References

No definition available.

+ Details

Name:	ifrs-full_DisclosureOfJointVenturesLineItems
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The amount of investments in joint ventures accounted for using the equity method. [Refer: Joint ventures [member]; Investments accounted for using equity method]

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2022-03-24
-Paragraph 55
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_55&doctype=Standard
-URIDate 2022-03-24

+ Details

Name:	ifrs-full_InvestmentsInJointVenturesAccountedForUsingEquityMethod
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Details

Name:	ifrs-full_JointVenturesAxis=adc_OverlandADCTBioPharmaCYLimitedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: